Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2017
DOI: 10.1158/1535-7163.mct-16-0750
|View full text |Cite
|
Sign up to set email alerts
|

PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells

Abstract: Cancer stem cells possess self-renewal and chemoresistance activities. However, the manner in which these features are maintained remains obscure. We sought to identify cell surface protein(s) that mark self-renewing and chemoresistant gastric cancer cells using the explorer antibody microarray. We identified PMP22, a target gene of the Wnt/β-catenin pathway, as the most upregulated cell surface protein in gastric cancer xenografts exposed to cisplatin (DDP). PMP22 expression was markedly upregulated in tumors… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(34 citation statements)
references
References 48 publications
(63 reference statements)
0
34
0
Order By: Relevance
“…159 PMP22, an integral membrane glycoprotein in myelin in the peripheral nervous system, induces the differentiation of gastric CSCs, but its mRNA level declines with activation of the Wnt/β-catenin pathway. 160 Moreover, TRAP1, a component of the HSP90 (heat-shock protein 90) chaperone family, inhibits the differentiation of colorectal carcinoma stem cells by modulating β-catenin ubiquitination and phosphorylation. 161 Lgr5, a member of the G proteincoupled receptor (GPCR) family of proteins, is located downstream of the Wnt signaling pathway and restrains the differentiation of esophageal SCC stem cells.…”
Section: Major Signaling Pathways In Cscsmentioning
confidence: 99%
“…159 PMP22, an integral membrane glycoprotein in myelin in the peripheral nervous system, induces the differentiation of gastric CSCs, but its mRNA level declines with activation of the Wnt/β-catenin pathway. 160 Moreover, TRAP1, a component of the HSP90 (heat-shock protein 90) chaperone family, inhibits the differentiation of colorectal carcinoma stem cells by modulating β-catenin ubiquitination and phosphorylation. 161 Lgr5, a member of the G proteincoupled receptor (GPCR) family of proteins, is located downstream of the Wnt signaling pathway and restrains the differentiation of esophageal SCC stem cells.…”
Section: Major Signaling Pathways In Cscsmentioning
confidence: 99%
“…While it is likely that Wnt6 + ‐resistant cells represent gCSCs, this was not formally demonstrated. More recently, investigations to identify cell‐surface proteins that mark chemoresistant and self‐renewing GC cells following chemotherapy (cisplatin) reveal enrichment for the cell‐surface glycoprotein PMP22 (Cai et al , ). PMP22, a Wnt target gene, is expressed in patients that had undergone perioperative chemotherapy, highlighting a strong correlation between PMP22 expression and tumour recurrence.…”
Section: Duplicitous Wnt Signalling – Regulator Of Both Normal and Camentioning
confidence: 99%
“…PMP22, a Wnt target gene, is expressed in patients that had undergone perioperative chemotherapy, highlighting a strong correlation between PMP22 expression and tumour recurrence. GC cells and tumour xenograft sensitivity to cisplatin were significantly increased when combined with pharmacological inhibition of PMP22 (Cai et al , ). The cell‐surface water channel protein aquaporin‐3 (AQP3) is overexpressed in GC tissues and promotes invasion and metastasis via EMT (Chen et al , ); however, its role in chemoresistance has only recently been investigated.…”
Section: Duplicitous Wnt Signalling – Regulator Of Both Normal and Camentioning
confidence: 99%
“…These results show that CCAR1 plays a role in gastric carcinogenesis and is a potential biomarker . Furthermore, an upregulation of PMP22, a Wnt/β‐catenin target gene, was found in GC cells resistant to cisplatin by Cai et al., and its inhibition decreased CSC properties both in vitro and in vivo. In this study, the treatment with a PMP22 inhibitor restores the sensibility to cisplatin treatment and PMP22 expression correlated with a worst clinical outcome in patients of GC.…”
Section: Gastric Cancer Stem Cellsmentioning
confidence: 63%
“…These results show that CCAR1 plays a role in gastric carcinogenesis and is a potential biomarker. 57 Furthermore, an upregulation of PMP22, a Wnt/β-catenin target gene, was found in GC cells resistant to cisplatin by Cai et al, 58 and its inhibition decreased CSC properties both in vitro and in vivo.…”
Section: Advances In Signaling Pathwaysmentioning
confidence: 97%